{
  "rejected_claims": [
    {
      "filename": "fda-compounding-pharmacy-closure-february-2025-eliminated-quasi-legal-affordable-glp1-access.md",
      "issues": [
        "missing_attribution_extractor"
      ]
    },
    {
      "filename": "gray-market-semaglutide-importation-will-build-despite-illegality-due-to-1185-monthly-arbitrage.md",
      "issues": [
        "missing_attribution_extractor"
      ]
    }
  ],
  "validation_stats": {
    "total": 2,
    "kept": 0,
    "fixed": 2,
    "rejected": 2,
    "fixes_applied": [
      "fda-compounding-pharmacy-closure-february-2025-eliminated-quasi-legal-affordable-glp1-access.md:set_created:2026-03-21",
      "gray-market-semaglutide-importation-will-build-despite-illegality-due-to-1185-monthly-arbitrage.md:set_created:2026-03-21"
    ],
    "rejections": [
      "fda-compounding-pharmacy-closure-february-2025-eliminated-quasi-legal-affordable-glp1-access.md:missing_attribution_extractor",
      "gray-market-semaglutide-importation-will-build-despite-illegality-due-to-1185-monthly-arbitrage.md:missing_attribution_extractor"
    ]
  },
  "model": "anthropic/claude-sonnet-4.5",
  "date": "2026-03-21"
}